Cardiac resynchronization therapy with or without defibrillator in patients with heart failure.

Benedikt SchrageLars H LundMichael MelinLina BensonAlicia UijlUlf DahlströmFrieder BraunschweigCecilia Linde Gianluigi Savarese

Published in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)

In a contemporary HFrEF cohort, CRT-D was associated with lower mortality compared with CRT-P. The CRT-D use was less likely in older patients, females, and in patients not referred to HF nurse-led outpatient clinic. Our findings support the use of CRT-D vs. CRT-P in HFrEF, in particular with severely reduced EF.

Keyphrases

cardiac resynchronization therapy
left ventricular
heart failure
end stage renal disease
primary care
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
cardiovascular events
acute heart failure
patient reported